Home/Filings/4/0000899243-22-006562
4//SEC Filing

Pavesio Alessandra 4

Accession 0000899243-22-006562

CIK 0001665988other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 9:53 PM ET

Size

7.0 KB

Accession

0000899243-22-006562

Insider Transaction Report

Form 4
Period: 2022-02-11
Pavesio Alessandra
SVP & Chief Science Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2022-02-11+1,470120,263 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-02-111,4700 total
    Class A Common Stock (1,470 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
  • [F2]The restricted stock units vested on February 11, 2022.

Issuer

Bioventus Inc.

CIK 0001665988

Entity typeother

Related Parties

1
  • filerCIK 0001835185

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 9:53 PM ET
Size
7.0 KB